case_images: PMC11222336_01
case_images: Comparison of abdominal magnetic resonance imaging (A,B,C) before and (D,E,F) after chemotherapy, the left retroperitoneal lymph nodes were significantly reduced.
case_images: fphar-15-1339662-g001.jpg
case_images: PMC11222336_01_fphar-15-1339662-g001.jpg
case_images: F1
case_images: Biopsy pathological results suggested embryonal carcinoma (Supplementary Figures S1, S2). After the four cycles, the left adrenal lesion had reduced by 53.6% (18.1 mm*12.7 mm*22.9 mm) (Figure 1).
case_images: After the fifth cycle of chemotherapy for testicular cancer, the lens of the right eye was completely white and cloudy.
case_images: fphar-15-1339662-g002.jpg
case_images: PMC11222336_01_fphar-15-1339662-g002.jpg
case_images: F2
case_images: Biopsy pathological results suggested embryonal carcinoma (Supplementary Figures S1, S2). No record of visual problems was found in his family members (Figure 2).
case_images: PET-CT after radiotherapy showed the metabolism in the lesion did not increase and enlarged lymph nodes were not found.
case_images: fphar-15-1339662-g003.jpg
case_images: PMC11222336_01_fphar-15-1339662-g003.jpg
case_images: F3
case_images: The B-ultrasound imaging of both eyes indicated opacity in the anterior crystalline region of the right eye (Supplementary Figures S3). After 10 months, this patient underwent a PET-CT scan, which showed a nodular shadow of the left adrenal gland with calcification (15.0 mm*12.0 mm*17.0 mm) and no evidence of residual highly active tumor tissue anywhere in the body, indicating complete response (CR) (Figures 3, 4).
case_images: Overview of the whole treatment process.
case_images: fphar-15-1339662-g004.jpg
case_images: PMC11222336_01_fphar-15-1339662-g004.jpg
case_images: F4
case_images: After 10 months, this patient underwent a PET-CT scan, which showed a nodular shadow of the left adrenal gland with calcification (15.0 mm*12.0 mm*17.0 mm) and no evidence of residual highly active tumor tissue anywhere in the body, indicating complete response (CR) (Figures 3, 4).